The Recombinant Human CD99 Fc Chimera Protein from R D Systems is derived from NS0 The Recombinant Human CD99 Fc Chimera Protein has been validated for the following applications Binding Activity

Gene Silencers generally consist of pools of three to five target-specific 19-25 nucleotide sequences in length. For independent verification of β2-chimaerin gene silencing results, individual duplex components or plasmids are also available upon request.

The CD40 Ligand/TNFSF5 Antibody (hu5c8 (Ruplizumab)) [PE/Cy5.5] - Chimeric from Novus is a CD40 Ligand/TNFSF5 antibody to CD40 Ligand/TNFSF5. This antibody reacts with Human. The CD40 Ligand/TNFSF5 antibody has been validated for the following applications:

The CD40 Ligand/TNFSF5 Antibody (hu5c8 (Ruplizumab)) [PE/Cy7] - Chimeric from Novus is a CD40 Ligand/TNFSF5 antibody to CD40 Ligand/TNFSF5. This antibody reacts with Human. The CD40 Ligand/TNFSF5 antibody has been validated for the following applications:

Recombinant Mouse CLEC4E Fc Chimera Protein, CF

Recombinant SARS-CoV-2 BA.2 Spike RBD Fc Chimera Protein, CF

The Recombinant Mouse IL 6 IL 6 R alpha Protein Chimera from R D Systems is derived from NS0 The Recombinant Mouse IL 6 IL 6 R alpha Protein Chimera has been validated for the

Recombinant Human CD177 Fc Chimera Protein, CF

Recombinant Mouse CD200R1L Fc Chimera Protein, CF

Recombinant Rat CD27/TNFRSF7 Fc Chimera Protein, CF

Gene Silencers generally consist of pools of three to five target-specific 19-25 nucleotide sequences in length. For independent verification of β2-chimaerin gene silencing results, individual duplex components or plasmids are also available upon request.

The CD40 Ligand/TNFSF5 Antibody (hu5c8 (Ruplizumab)) [Alexa Fluor® 594] - Chimeric from Novus is a CD40 Ligand/TNFSF5 antibody to CD40 Ligand/TNFSF5. This antibody reacts with Human. The CD40 Ligand/TNFSF5 antibody has been validated for the